Akero Therapeutics Inc (AKRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | AKRO | KNSA | SYRE | ||
Company | Akero Therapeutics Inc | Kiniksa Pharmaceuticals Ltd | Spyre Therapeutics Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 20.32 | 20.13 | 37.00 | ||
High | 20.75 | 20.40 | 39.04 | ||
Low | 20.28 | 19.94 | 37.00 | ||
Last | 20.37 | 20.03 | 37.67 | ||
Change | +0.66 | +0.65 | +1.40 | ||
% Change | +3.35% | +3.35% | +3.86% | ||
Volume | 33,224 | 72,907 | 27,015 | ||
20-Day Average Volume | 669,069 | 386,788 | 316,134 | ||
Previous Close | 19.71 | 19.38 | 36.27 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | Yes | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 20.98 | 17.89 | 35.49 | ||
20-Day Raw Stochastic | 39.21% | 90.63% | 72.87% | ||
20-Day Relative Strength | 41.67% | 62.33% | 56.64% | ||
Weighted Alpha | +10.37 | +42.18 | +155.76 | ||
Today's Opinion | 72% Sell | 72% Buy | 72% Buy | ||
Previous Opinion | 72% Sell | 48% Buy | 72% Buy | ||
Last Month's Opinion | 40% Sell | 40% Buy | 88% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | +3.24% since 04/26/24 | +12.08% since 04/26/24 | +13.95% since 04/26/24 | ||
Low | 19.31 on 04/29/24 | 17.79 on 04/29/24 | 31.39 on 05/01/24 | ||
High | 20.75 on 05/03/24 | 20.40 on 05/03/24 | 39.04 on 05/03/24 | ||
1-Month | |||||
%Chg | -12.08% since 04/03/24 | +9.87% since 04/03/24 | +10.33% since 04/03/24 | ||
Low | 18.20 on 04/25/24 | 16.56 on 04/19/24 | 31.27 on 04/25/24 | ||
High | 23.89 on 04/04/24 | 20.40 on 05/03/24 | 40.83 on 04/12/24 | ||
3-Month | |||||
%Chg | -2.07% since 02/02/24 | +9.03% since 02/02/24 | +48.56% since 02/02/24 | ||
Low | 15.32 on 02/06/24 | 16.56 on 04/19/24 | 20.07 on 02/22/24 | ||
High | 37.00 on 03/04/24 | 22.09 on 03/04/24 | 47.97 on 03/18/24 | ||
6-Month | |||||
%Chg | +39.78% since 11/03/23 | +23.70% since 11/03/23 | +238.11% since 11/03/23 | ||
Low | 13.39 on 11/10/23 | 14.12 on 11/10/23 | 8.43 on 11/10/23 | ||
High | 37.00 on 03/04/24 | 22.09 on 03/04/24 | 47.97 on 03/18/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 1,362,966 | 1,368,519 | 1,311,197 | ||
Shares Outstanding, K | 69,151 | 70,615 | 36,151 | ||
Annual Sales | 0 | 270,260,000 | 890,000 | ||
Annual Net Income | -151,760,000 | 14,080,000 | -338,790,000 | ||
Last Quarter Sales | 0 | 79,860,000 | 0 | ||
Last Quarter Net Income | -55,190,000 | -17,700,000 | -40,110,000 | ||
60-Month Beta | -0.29 | 0.32 | 2.93 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.99 on 02/29/24 | -0.25 on 04/23/24 | -2.28 on 02/29/24 | ||
Latest Earnings Date | 05/20/24 | 04/23/24 | 05/09/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |